Antimicrobial Resistance and COVID-19: How Congress Can Address Converging Crises

On July 23, IDSA hosted a briefing for congressional staff with BIO, Cystic Fibrosis Foundation, Duke-Margolis Center for Health Policy, Partnership to Fight Infectious Disease and The Pew Charitable Trusts.  The briefing, “Antimicrobial Resistance and COVID-19: How Congress can Address Converging Crises” featured IDSA Treasurer Helen Boucher, MD, FIDSA, a patient, and other experts discussing how AMR and a lack of new antibiotics are complicating care for patients with COVID-19 and other conditions.  The panelists also discussed congressional proposals, including the PASTEUR Act, DISARM Act and increased funding, that could strengthen the antibiotic pipeline and promote antibiotic stewardship.